Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters
Danish pharmaceutical company Lundbeck is relocating its US headquarters from Deerfield, Illinois, to Greater Boston, Massachusetts. The move aims to establish a global innovation hub within a leading life sciences ecosystem.
H. Lundbeck A/S announced it will move its US headquarters from Deerfield, Illinois, to Greater Boston, Massachusetts, establishing a global innovation hub. The relocation places the company within a significant life sciences ecosystem, aiming to enhance access to science, talent, and partnerships.
The strategic move is part of Lundbeck's ongoing investment in the US market and supports the next phase of its Focused Innovator strategy. The new hub is intended to scale the company's growing neuroscience portfolio, expand innovation opportunities, and bolster digital and artificial intelligence capabilities.
"The US has been an important driver of Lundbeck's commercial progress and remains central to our future growth ambitions," said Charl van Zyl, President and CEO of Lundbeck. "Our investment in Greater Boston is an important step in positioning Lundbeck to capture those opportunities and bring innovative treatments to more people living with brain diseases."
The transition from Deerfield is scheduled to occur over the next year. Lundbeck, with over 70 years of experience in neuroscience, aims to improve the lives of individuals with neurological and psychiatric conditions. The company intends to retain its US workforce and ensure business continuity during the relocation.